Proficiency Testing/EQA / Genetics and Molecular Pathology / Next-Generation Sequencing Help Please log in to determine if you are eligible to purchase PT Programs. NGS HEMATOLOGIC MALIGNANCIES - NGSHM Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Procedure Challenges per Shipment Number of Shipments Next‑generation sequencing 3 Two shipments per year Additional Information This is a methods‑based proficiency challenge for laboratories performing targeted next‑generation sequencing of genes or mutation hotspots in hematologic malignancies. This program includes variants present with a variant allele fraction (VAF) potentially as low as 5%. Program Information Three 1.0‑μg gDNA (50 ng/μL) specimens Shipping Schedule Shipment A: May 1 Shipment B: October 30 Guest Log in/Register Customers Who Bought This Item Also Bought NGS SOLID TUMOR VIEW DETAILS > NGS BIOINFORMATICS HYBRID - HEME MALIGNANCIES VIEW DETAILS >